drugset / Trial / NCT04711226
Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety, tolerability and efficacy of AT-1501 in an immunomodulation regimen in adult patients with T1D undergoing an islet cell transplant.
Timeline
- Start
- 2021-02-19
- Primary completion
- 2024-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tegoprubart | Monoclonal antibody | — | Intravenous |